Violetta Marafioti

89133, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma.

The Great Debate: CAR-T-Cell Therapy Versus Bispecific Antibodies in B-Cell Lymphoma.

Journal: Cancers
Published: July 01, 2026

Menin Inhibition in Acute Myeloid MLL Rearranged Leukemias: A New Target for Precision Care.

Menin Inhibition in Acute Myeloid MLL Rearranged Leukemias: A New Target for Precision Care.

Journal: Cancers
Published: January 20, 2026

Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia?

Is There a Future for CAR-T Therapy in Acute Myeloid Leukemia?

Journal: Cancers
Published: December 02, 2025

Efficacy of Polyvinylpyrrolidone-Zinc Gluconate and Taurine Gel in the Prophylaxis of Oral Mucositis in Adults Undergoing High-Dose Chemotherapy and Allogeneic Stem Cell Transplantation.

Efficacy of Polyvinylpyrrolidone-Zinc Gluconate and Taurine Gel in the Prophylaxis of Oral Mucositis in Adults Undergoing High-Dose Chemotherapy and Allogeneic Stem Cell Transplantation.

Journal: Diseases (Basel, Switzerland)
Published: October 30, 2025

CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues.

CAR-T Cell Therapies in B-Cell Acute Lymphoblastic Leukemia: Emerging Data and Open Issues.

Journal: Cancers
Published: August 06, 2025

CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern Italy.

CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern Italy.

Journal: Cancers
Published: July 19, 2025

Treatment Strategies Used in Treating Myelofibrosis: State of the Art.

Treatment Strategies Used in Treating Myelofibrosis: State of the Art.

Journal: Hematology reports
Published: August 29, 2024

First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study.

First-Line Use of Daratumumab in Patients with Multiple Myeloma Shows Delayed Neutrophil and Platelet Engraftment after Autologous Stem Cell Transplantation: Results from a Real-Life Single-Center Study.

Journal: Cancers
Published: August 20, 2024

Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?

Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?

Journal: Expert review of hematology
Published: July 17, 2024

Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience.

Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience.

Journal: Frontiers in oncology
Published: August 23, 2022

Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up.

Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up.

Journal: Cancers
Published: February 17, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026